Ionis Completes Pivotal Cohort Enrollment in Phase 3 REVEAL Study
Ionis Pharmaceuticals Completes Enrollment in Pivotal Phase 3 REVEAL Study Cohort Evaluating Obudanersen for Angelman Syndrome Ionis Pharmaceuticals, Inc. has announced the completion of enrollment in the pivotal pediatric cohort…
Alzheon to Present New Valiltramiprosate Data at AAIC 2026
Alzheon to Present Nine Scientific Posters at AAIC 2026 Highlighting New Clinical, Imaging, Biomarker, and Long-Term Data for Investigational Alzheimer’s Therapy Valiltramiprosate Alzheon, Inc., a clinical-stage biopharmaceutical company focused on…
Signatera™ MRD Test Predicts Survival Benefit from Chemotherapy in Metastatic Colorectal Cancer
Signatera™ MRD Test Predicts Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer Natera, Inc., a global leader in cell-free DNA testing and precision medicine, has announced the publication…
Novartis Wins European Commission Approval for Itvisma® in SMA
Novartis Secures EU Approval for Itvisma® in SMA Novartis has announced that the European Commission (EC) has granted approval for Itvisma® (onasemnogene abeparvovec) for the treatment of children aged two…
Immunomic Therapeutics Doses First Patient in Phase 1 Trial of ITI-9001
Immunomic Therapeutics Doses First Participant in Phase 1 Trial of ITI-9001 Therapeutic Vaccine for Japanese Cedar Pollen Allergy Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and subsidiary of HLB,…
Visby Medical Wins FDA Clearance for First At-Home PCR Respiratory Virus Test
Visby Medical Receives FDA Clearance for First At-Home Multi-Viral PCR Test for COVID-19 and Influenza Visby Medical, a company focused on developing rapid molecular diagnostics for use at home, has…
Arima Genomics Partners with Active Motif to Expand Hi-C Sequencing Access
Arima Genomics Partners with Active Motif to Expand Access to Hi-C Research Technologies While Accelerating Clinical Cancer Diagnostics Strategy Arima Genomics, Inc., a biotechnology company focused on advancing precision oncology…
AGC Pharma Chemicals Validates CDMO Facilities Through VERIF.i® Program
AGC Pharma Chemicals Validates New Barcelona CDMO Facility Through Scientist.com’s VERIF.i® Supplier Assessment Program AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) specializing in small molecule…
PeptiDream Announces Multiple Executive Leadership Appointments
PeptiDream Strengthens Executive Leadership Team with Three New Executive Vice Presidents to Accelerate Global Growth PeptiDream Inc., a publicly traded biopharmaceutical company headquartered in Kawasaki, Japan, has announced the appointment…
US Heart & Vascular Announces Georgia Expansion Through Two Cardiology Partnerships
US Heart and Vascular Expands Georgia Presence Through Partnerships with Cardiovascular Clinic of North Georgia and Cardiology of Atlanta US Heart and Vascular, a national provider of administrative and operational…
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Early Vessel Recoil in High-Risk CLTI Patients Reflow Medical, Inc. has announced the enrollment of the first participant…
Arcturus Therapeutics Partners with Thermo Fisher to Advance ARCT-032 for Cystic Fibrosis
Arcturus Therapeutics and Thermo Fisher Scientific Form Strategic Collaboration to Advance ARCT-032 for Cystic Fibrosis Through Phase 3 Development and Potential Commercialization Arcturus Therapeutics Holdings Inc., a clinical-stage messenger RNA…